To test the hypothesis that progressive endothelial dysfunction and loss of endothelial EPCR expression may underlie the observed reduction in sEPCR levels, age- and sex-matched patients with PAD stage III/IV were prospectively recruited. The gene discussed is PROCR; the disease is endothelial dysfunction.